The association between medication non-adherence and adverse health outcomes in ageing populations: A systematic review and meta-analysis

被引:150
作者
Walsh, Caroline A. [1 ]
Cahir, Caitriona [1 ]
Tecklenborg, Sarah [1 ]
Byrne, Catherine [1 ]
Culbertson, Michael A. [2 ]
Bennett, Kathleen E. [1 ]
机构
[1] Royal Coll Surgeons Ireland, Div Populat Hlth Sci, Beaux Lane House,Lower Mercer St, Dublin, Ireland
[2] Univ Dublin, Trinity Coll Dublin, Sch Psychol, Dublin, Ireland
关键词
ageing population; hospitalisation; medication adherence; mortality; ALL-CAUSE MORTALITY; QUALITY-OF-LIFE; ORAL BISPHOSPHONATE THERAPY; SELF-REPORTED ADHERENCE; CARDIOVASCULAR-DISEASE; CARE UTILIZATION; HEART-FAILURE; OLDER-ADULTS; FRACTURE RISK; DRUG-THERAPY;
D O I
10.1111/bcp.14075
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims The aim of this systematic review and meta-analysis was to synthesise the evidence relating to medication non-adherence and its association with health outcomes in people aged >= 50 years. Methods Seven databases were searched up to February 2019 for observational studies that measured medication (non-)adherence as a predictor of the following health outcomes in adults aged >= 50 years: healthcare utilisation (hospitalisation, emergency department visits, outpatient visits and general practitioner visits), mortality, adverse clinical events and quality of life. Screening and quality assessment using validated criteria were completed by 2 reviewers independently. Random effects models were used to generate pooled estimates of association using adjusted study results. The full methodological approach was published on PROSPERO (ID: CRD42017077264). Results Sixty-six studies were identified for qualitative synthesis, with 11 of these studies eligible for meta-analyses. A meta-analysis including 3 studies measuring medication non-adherence in adults aged >= 55 years showed a significant association with all-cause hospitalisation (adjusted odds ratio 1.17, 95% confidence interval [CI] 1.12, 1.21). A meta-analysis including 2 studies showed that medication non-adherence was not significantly associated with an emergency department visit (adjusted odds ratio 1.05, 95% CI 0.90, 1.22). Good adherence was associated with a 21% reduction in long-term mortality risk in comparison to medication non-adherence (adjusted hazard ratio 0.79, 95% CI 0.63, 0.98). Conclusion Medication non-adherence may be significantly associated with all-cause hospitalisation and mortality in older people. Medication adherence should be monitored and addressed in this cohort to minimise hospitalisation, improve clinical outcomes and reduce healthcare costs.
引用
收藏
页码:2464 / 2478
页数:15
相关论文
共 116 条
[41]   Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: A systematic review [J].
Ho, Siew Ching ;
Chong, Huey Yi ;
Chaiyakunapruk, Nathorn ;
Tangiisuran, Balamurugan ;
Jacob, Sabrina Anne .
JOURNAL OF AFFECTIVE DISORDERS, 2016, 193 :1-10
[42]   Association of medication adherence, knowledge, and skills with emergency department visits by adults 50 years or older with congestive heart failure [J].
Hope, CJ ;
Wu, JW ;
Tu, WZ ;
Young, J ;
Murray, MD .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (19) :2043-2049
[43]   Medication adherence and health-related quality of life among patients with chronic obstructive pulmonary disease [J].
Horvat, Nejc ;
Locatelli, Igor ;
Kos, Mitja ;
Janezic, Ana .
ACTA PHARMACEUTICA, 2018, 68 (01) :117-125
[44]   Interruption and Non-Adherence to Long-Term Adjuvant Hormone Therapy Is Associated with Adverse Survival Outcome of Breast Cancer Women - An Asian Population-Based Study [J].
Hsieh, Kun-Pin ;
Chen, Li-Chia ;
Cheung, Kwok-Leung ;
Chang, Chao-Sung ;
Yang, Yi-Hsin .
PLOS ONE, 2014, 9 (02)
[45]   Medication non-adherence in the elderly - How big is the problem? [J].
Hughes, CM .
DRUGS & AGING, 2004, 21 (12) :793-811
[46]   Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis [J].
Imaz, I. ;
Zegarra, P. ;
Gonzalez-Enriquez, J. ;
Rubio, B. ;
Alcazar, R. ;
Amate, J. M. .
OSTEOPOROSIS INTERNATIONAL, 2010, 21 (11) :1943-1951
[47]   Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis [J].
Karlsson, L. ;
Lundkvist, J. ;
Psachoulia, E. ;
Intorcia, M. ;
Strom, O. .
OSTEOPOROSIS INTERNATIONAL, 2015, 26 (10) :2401-2411
[48]  
Keshishian A, 2017, J MANAG CARE SPEC PH, V23, P1178, DOI 10.18553/jmcp.2017.17054
[49]   Impact of a Better Adherence to Antihypertensive Agents on Cerebrovascular Disease for Primary Prevention [J].
Kettani, Fatima-Zohra ;
Dragomir, Alice ;
Cote, Robert ;
Roy, Louise ;
Berard, Anick ;
Blais, Lucie ;
Lalonde, Lyne ;
Moreau, Pierre ;
Perreault, Sylvie .
STROKE, 2009, 40 (01) :213-220
[50]   Adherence to Inhaled Medications and its Effect on Healthcare Utilization and Costs Among High-Grade Chronic Obstructive Pulmonary Disease Patients [J].
Kim, Jee-Ae ;
Lim, Min Kyoung ;
Kim, Kunil ;
Park, JuHee ;
Rhee, Chin Kook .
CLINICAL DRUG INVESTIGATION, 2018, 38 (04) :333-340